BioMarin Pharma (BMRN) Trades Higher After Pfizer (PFE) Wins Medivation (MDVN) (SNY)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/18/2024
- Asia stocks bounce as soaring dollar pauses
- Taiwan Semi (TSM) Q1 profit beats expectations on AI demand
- Dollar rally stalls after rare FX warning from finance chiefs
- Oil stabilises after sharp drop on demand concerns, easing of Middle East tension
- Netflix's subscribers, TSMC, Tesla upside - what's moving markets
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Alaska Airlines flights resume after being grounded over aircraft system issue
- Crude Inventory Rose 2.7 Million Barrels Last Week, Says EIA
- Lithium Americas Corp (LAC) Announces Proposed 55M Share Offering
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
Pfizer (PFE) Near Deal to Acquire Medivation (MDVN) for $14 Billion
August 22, 2016 12:33 AM EDTPfizer (NYSE: PFE) is near a deal to acquire Medivation (NASDAQ: MDVN) for just shy of $14 billion in cash, or about $80 per share, according to various media reports late Sunday. A deal could be announced as soon as Monday.
The offer comes at a sharp premium to the $52.50 per... More
